CompletedPhase 2NCT00873457

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Studying B-cell chronic lymphocytic leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Daphne Friedman
Principal Investigator
Daphne Friedman, MD
Duke University
Intervention
perifosine(drug)
Enrollment
16 target
Eligibility
18 years · All sexes
Timeline
2009 – 2013

Study locations (1)

Collaborators

Keryx Biopharmaceuticals · Keryx / AOI Pharmaceuticals, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00873457 on ClinicalTrials.gov

Other trials for B-cell chronic lymphocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for B-cell chronic lymphocytic leukemia →

← Back to all trials